Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-11-28
2006-11-28
Habte, Kahsay (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S060000, C544S073000, C544S099000, C540S553000, C514S218000, C514S228500
Reexamination Certificate
active
07141565
ABSTRACT:
The present invention relates to quinobenzoxazines analogs having the general formula:and pharmaceutically acceptable salts, esters and prodrugs thereof;wherein A, U, V, W, X and Z are substituents.The present invention also relates to methods for using such compounds.
REFERENCES:
patent: 4533663 (1985-08-01), Chu
patent: 4559157 (1985-12-01), Smith et al.
patent: 4608392 (1986-08-01), Jacquet et al.
patent: 4725595 (1988-02-01), Schriewer et al.
patent: 4820508 (1989-04-01), Wortzman
patent: 4938949 (1990-07-01), Borch et al.
patent: 4992478 (1991-02-01), Geria
patent: 5225418 (1993-07-01), Miller
patent: 5318965 (1994-06-01), Chu et al.
patent: 5624924 (1997-04-01), Chu et al.
patent: 5703055 (1997-12-01), Felgner et al.
patent: 6214560 (2001-04-01), Yguerabide et al.
patent: 6528517 (2003-03-01), Hurley et al.
patent: 6645981 (2003-11-01), Ledoussal et al.
patent: 6900224 (2005-05-01), Ledoussal et al.
patent: 2002/0049223 (2002-04-01), Elmore et al.
patent: 2003/0232818 (2003-12-01), Anderson et al.
patent: 2004/0029882 (2004-02-01), Ledoussal et al.
patent: 2004/0072817 (2004-04-01), Anderson et al.
patent: 2005/0159423 (2005-07-01), Anderson et al.
patent: 02040379 (1990-02-01), None
patent: WO 92/03136 (1992-03-01), None
patent: WO-04/014893 (2004-02-01), None
patent: WO-04/091627 (2004-10-01), None
Anantha et al., Biochemistry (1998) 37:2709-2714.
Ansell et al., Current Opinion in Biotechnology (1996) 7:89-94.
Berge et al., J. Pharm. Sci. (1977) 66:1-19.
Datta et al., JACS (2001) 123:9612-9619.
Gibson et al., Genome Res. (1996) 6:995-1001.
Han et al., Nucl. Acids Res. (1999) 27:537-542.
Han et al., Trends Pharm. Sci. (2000) 21:136-142.
He at al., Science (1998) 281:1509-1512.
Heid et al., Genome Res. (1996) 6:986-994.
Henegariu et al., Nature Biotech (2000) 18:345-348.
Jin and Pike, Mol. Endocrinol. (1996) 10:196-205.
Kim et al., J. of Medicinal Chemistry (2003) 46(4):571-583.
Kriz et al., Analytical Chemistry (1995) 67:2142-2144.
Qu and Chaires, Methods Enzymol (2000) 321:353-369.
Shea, Trends in Polymer Science (1994) 2:166-173.
Tomita et al., J. Med. Chem. (2002) 45:5564-5575.
Vaickus, Crit. Rev. in Oncol./Hemotol. (1991) 11:267-297.
Vlatakis et al., Nature (1993) 361:645-647.
Wang et al., Methods Cell Sci (1996) 18:249-255.
Weitzmann et al., J. Biol. Chem. (1996) 271:20958-20964.
Zeng et al., J. Med. Chem. (1998) 41:4273-4278.
Moran Terrance
Schwaebe Michael
Siddiqui-Jain Adam
Whitten Jeffrey P.
Cylene Pharmaceuticals, Inc.
Habte Kahsay
Morrison & Foerster / LLP
LandOfFree
Substituted quinobenzoxazine analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted quinobenzoxazine analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted quinobenzoxazine analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3635211